Gilead Sciences, Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Foster City, CA
GILD chart
What traders are saying about $GILD
Latest postsGilead Sciences, Inc. news
- Can Gilead’s Cash Keep Growing?
trefis.com ·
- Gilead Sciences Targets 200 Treatment Centers for Potential Anito-Cel Launch
marketbeat.com ·
- Merck vs. Gilead Sciences: Which Dividend Stock Pays You More in 10 Years?
tikr.com ·
- Gilead Sciences stock gains fresh support from HIV prevention data
ad-hoc-news.de ·
- Gilead Sciences, Inc. (GILD) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- Gilead Sciences, Inc. $GILD Stock Bought by M&G PLC
MarketBeat ·
- Gilead Sciences Stock Hits a New All-Time High: Is it Still a Good Buy?
fool.com ·
- Alps Advisors Inc. Sells 45,008 Shares of Gilead Sciences, Inc. $GILD
MarketBeat ·
- Gilead Sciences stock slips to EUR 150.26, down 0.58% premarket
ad-hoc-news.de ·
- Gilead Sciences (NASDAQ:GILD) Stock: Insider Wettan Keeley Cain Sells 3,399 Shares
MarketBeat ·
- Gilead Sciences (GILD) Insider Sale: EVP Gen Counsel, Legal & Co
GuruFocus ·
- Form 4 Gilead Sciences Inc: Wettan Keeley M. Cain (EVP Gen Counsel, Legal & Comp) For: 6 November
Investing.com Canada ·
Gilead Sciences, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $29.44B | $28.75B | $27.12B | $27.28B |
| Net income | $8.51B | $480.0M | $5.67B | $4.59B |
| Diluted EPS | $6.78 | $0.38 | $4.50 | $3.64 |
| Total assets (year end) | $59.02B | $58.99B | $62.13B | $63.17B |
| Cash and equivalents (year end) | – | – | – | $5.41B |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Gilead Sciences, Inc.
- Ticker
- GILD (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Foster City, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 882095
- Former names
- GILEAD SCIENCES INC
Frequently asked questions
What exchange is Gilead Sciences, Inc. listed on?
Gilead Sciences, Inc. trades on the Nasdaq under the ticker symbol GILD.
What industry is Gilead Sciences, Inc. in?
Gilead Sciences, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Gilead Sciences, Inc. headquartered?
Gilead Sciences, Inc.'s business address on file with the SEC is in Foster City, CA.
When does Gilead Sciences, Inc.'s fiscal year end?
Gilead Sciences, Inc.'s fiscal year ends on December 31.
How much revenue did Gilead Sciences, Inc. report?
Gilead Sciences, Inc. reported $29.44B in revenue for calendar year 2025, according to its SEC filings.